CompuVax's Unattributed Round

CompuVax raised a round of funding on April 14, 2015.

CompuVax aims to become a leading source of engineered antigens, the key components of future viral vaccines. In addition to vaccine design, the company has two pathways to develop novel antibody ther…

Articles about CompuVax's Unattributed Round: